Annual EBITDA
-$158.23 M
-$37.52 M-31.08%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual EBITDA is -$158.23 million, with the most recent change of -$37.52 million (-31.08%) on December 31, 2023.
- During the last 3 years, PLRX annual EBITDA has fallen by -$117.89 million (-292.28%).
- PLRX annual EBITDA is now -133991.53% below its all-time high of -$118.00 thousand, reached on December 31, 2019.
Performance
PLRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$56.35 M
-$1.99 M-3.66%
September 30, 2024
Summary
- As of February 7, 2025, PLRX quarterly EBITDA is -$56.35 million, with the most recent change of -$1.99 million (-3.66%) on September 30, 2024.
- Over the past year, PLRX quarterly EBITDA has dropped by -$1.99 million (-3.66%).
- PLRX quarterly EBITDA is now -232.56% below its all-time high of $42.51 million, reached on December 31, 2019.
Performance
PLRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$197.04 M
-$15.63 M-8.62%
September 30, 2024
Summary
- As of February 7, 2025, PLRX TTM EBITDA is -$197.04 million, with the most recent change of -$15.63 million (-8.62%) on September 30, 2024.
- Over the past year, PLRX TTM EBITDA has dropped by -$15.63 million (-8.62%).
- PLRX TTM EBITDA is now -878.93% below its all-time high of $25.30 million, reached on March 31, 2020.
Performance
PLRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PLRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.1% | -3.7% | -8.6% |
| 3 y3 years | -292.3% | -3.7% | -8.6% |
| 5 y5 years | -423.1% | -232.6% | -10000.0% |
PLRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -65.3% | at low | -135.7% | at low | -105.8% | at low |
| 5 y | 5-year | <-9999.0% | at low | -232.6% | at low | -878.9% | at low |
| alltime | all time | <-9999.0% | at low | -232.6% | at low | -878.9% | at low |
Pliant Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$56.35 M(+3.7%) | -$197.04 M(+8.6%) |
| Jun 2024 | - | -$54.36 M(+18.2%) | -$181.41 M(+8.3%) |
| Mar 2024 | - | -$46.00 M(+14.1%) | -$167.44 M(+5.8%) |
| Dec 2023 | -$158.23 M(+31.1%) | -$40.32 M(-1.0%) | -$158.23 M(+4.0%) |
| Sep 2023 | - | -$40.72 M(+0.8%) | -$152.19 M(+7.7%) |
| Jun 2023 | - | -$40.40 M(+9.8%) | -$141.33 M(+8.8%) |
| Mar 2023 | - | -$36.78 M(+7.3%) | -$129.85 M(+7.6%) |
| Dec 2022 | -$120.71 M(+26.1%) | -$34.29 M(+14.8%) | -$120.71 M(+9.4%) |
| Sep 2022 | - | -$29.86 M(+3.3%) | -$110.33 M(+2.9%) |
| Jun 2022 | - | -$28.91 M(+4.6%) | -$107.19 M(+6.3%) |
| Mar 2022 | - | -$27.64 M(+15.6%) | -$100.81 M(+5.3%) |
| Dec 2021 | -$95.73 M | -$23.91 M(-10.5%) | -$95.73 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$26.73 M(+18.6%) | -$90.49 M(+13.0%) |
| Jun 2021 | - | -$22.53 M(-0.1%) | -$80.09 M(+7.9%) |
| Mar 2021 | - | -$22.56 M(+20.8%) | -$74.22 M(+84.0%) |
| Dec 2020 | -$40.34 M(>+9900.0%) | -$18.67 M(+14.3%) | -$40.34 M(-293.5%) |
| Sep 2020 | - | -$16.33 M(-1.9%) | $20.85 M(-13.5%) |
| Jun 2020 | - | -$16.66 M(-247.1%) | $24.10 M(-4.7%) |
| Mar 2020 | - | $11.32 M(-73.4%) | $25.30 M(<-9900.0%) |
| Dec 2019 | -$118.00 K(-99.6%) | $42.51 M(-425.1%) | -$118.00 K(-99.7%) |
| Sep 2019 | - | -$13.07 M(-15.4%) | -$42.63 M(+44.2%) |
| Jun 2019 | - | -$15.46 M(+9.7%) | -$29.55 M(+109.7%) |
| Mar 2019 | - | -$14.09 M | -$14.09 M |
| Dec 2018 | -$30.25 M | - | - |
FAQ
- What is Pliant Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Pliant Therapeutics?
- What is Pliant Therapeutics annual EBITDA year-on-year change?
- What is Pliant Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly EBITDA year-on-year change?
- What is Pliant Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Pliant Therapeutics?
- What is Pliant Therapeutics TTM EBITDA year-on-year change?
What is Pliant Therapeutics annual EBITDA?
The current annual EBITDA of PLRX is -$158.23 M
What is the all time high annual EBITDA for Pliant Therapeutics?
Pliant Therapeutics all-time high annual EBITDA is -$118.00 K
What is Pliant Therapeutics annual EBITDA year-on-year change?
Over the past year, PLRX annual EBITDA has changed by -$37.52 M (-31.08%)
What is Pliant Therapeutics quarterly EBITDA?
The current quarterly EBITDA of PLRX is -$56.35 M
What is the all time high quarterly EBITDA for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly EBITDA is $42.51 M
What is Pliant Therapeutics quarterly EBITDA year-on-year change?
Over the past year, PLRX quarterly EBITDA has changed by -$1.99 M (-3.66%)
What is Pliant Therapeutics TTM EBITDA?
The current TTM EBITDA of PLRX is -$197.04 M
What is the all time high TTM EBITDA for Pliant Therapeutics?
Pliant Therapeutics all-time high TTM EBITDA is $25.30 M
What is Pliant Therapeutics TTM EBITDA year-on-year change?
Over the past year, PLRX TTM EBITDA has changed by -$15.63 M (-8.62%)